VERA

Vera TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

AI scenario view

RankAlpha Sentiment Codex

Most likely

B+

Bull case

35%

Probability

Target price

$70.00

+81.8% vs current

Base case

30%

Probability

Target price

$46.00

+19.5% vs current

B-

Bear case

35%

Probability

Target price

$18.00

-53.2% vs current

AI sentiment snapshot

Latest data as of 2026-07-02

AI commentary

Tone is cautiously positive because the evidence packet contains strong primary-source support for a near-term approval catalyst and a defined follow-on data timeline, but coverage is still thin and the setup is highly binary. Recent buzz appears centered on the June 2 FDA-alignment update rather than broad multi-source confirmation, so this remains a monitoring-style positive setup rather than a high-confidence fundamental call.

RankAlpha Sentiment Codex - 2026-07-02

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-07-07eventJuly 7, 2026 FDA PDUFA for accelerated approval in IgANHigh impact

The key near-term binary is atacicept's July 7, 2026 PDUFA date for accelerated approval in adult IgAN, with management also stating it is on track for a mid-2026 U.S. launch if approved [#SEC-8K-2026-05-07].

2026-09-30catalystORIGIN 3 eGFR update shifted into Q3 2026High impact

Vera said it aligned with FDA on a revised earlier ORIGIN 3 eGFR analysis plan, with eGFR results now expected in Q3 2026 and a supplemental BLA for full approval planned in Q4 2026 if supportive [#8-K-2026-06-02].

2027-07-02catalystLaunch execution and runway through potential approvalHigh impact

Company-reported Q1 context showed $596.8 million of cash, cash equivalents, and marketable securities as of March 31, 2026, which management said should fund operations through potential approval and U.S. launch and beyond, supporting commercialization readiness but not eliminating launch risk [#SEC-8K-2026-05-07].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-02 • Updated nightlySource: Internal modelMethodology